These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
148 related articles for article (PubMed ID: 2825916)
21. Antinociceptive interactions between alpha 2-adrenergic and opiate agonists at the spinal level in rodents. Ossipov MH; Suarez LJ; Spaulding TC Anesth Analg; 1989 Mar; 68(3):194-200. PubMed ID: 2537587 [TBL] [Abstract][Full Text] [Related]
22. Clonidine suppression of noradrenergic hyperactivity during morphine withdrawal by clonidine: biochemical studies in rodents and primates. Roth RH; Elsworth JD; Redmond DE J Clin Psychiatry; 1982 Jun; 43(6 Pt 2):42-6. PubMed ID: 6806253 [TBL] [Abstract][Full Text] [Related]
23. Effects of centrally administered naloxone on gastrointestinal myoelectrical activity in morphine-dependent rats. Primi MP; Bueno L J Pharmacol Exp Ther; 1987 Jan; 240(1):320-6. PubMed ID: 3806394 [TBL] [Abstract][Full Text] [Related]
24. Effects of clonidine on morphine withdrawal signs in the rat. Tseng LF; Loh HH; Wei ET Eur J Pharmacol; 1975 Jan; 30(1):93-9. PubMed ID: 1168138 [TBL] [Abstract][Full Text] [Related]
25. Effects of opioid antagonists and their quaternary analogs on temperature changes in morphine-dependent rats. Katovich MJ; Simpkins JW; O'Meara J Life Sci; 1986 Nov; 39(20):1845-54. PubMed ID: 3773644 [TBL] [Abstract][Full Text] [Related]
26. Effect of oxytocin pretreatment on the development of morphine tolerance and dependence in rats. Özdemir-Çezik S; Nurten A; Midilli B; Gürtekin B; Enginar N Neurosci Lett; 2022 Jul; 784():136764. PubMed ID: 35764224 [TBL] [Abstract][Full Text] [Related]
27. Noradrenergic and behavioural effects of naloxone injected in the locus coeruleus of morphine-dependent rats and their control by clonidine. Esposito E; Kruszewska A; Ossowska G; Samanin R Psychopharmacology (Berl); 1987; 93(3):393-6. PubMed ID: 3124170 [TBL] [Abstract][Full Text] [Related]
28. Effect of chronic estrogen on the skin temperature response to naloxone in morphine-dependent rats. Katovich MJ; O'Meara J Can J Physiol Pharmacol; 1987 Apr; 65(4):563-7. PubMed ID: 3607603 [TBL] [Abstract][Full Text] [Related]
29. Intrathecal morphine and clonidine: antinociceptive tolerance and cross-tolerance and effects on blood pressure. Solomon RE; Gebhart GF J Pharmacol Exp Ther; 1988 May; 245(2):444-54. PubMed ID: 3367301 [TBL] [Abstract][Full Text] [Related]
30. On the relationship between clonidine hypotension and brain beta-endorphin in the spontaneously hypertensive rat: studies with alpha adrenergic and opiate blockers. Mastrianni JA; Ingenito AJ J Pharmacol Exp Ther; 1987 Jul; 242(1):378-87. PubMed ID: 3039113 [TBL] [Abstract][Full Text] [Related]
31. Brain reward deficits accompany naloxone-precipitated withdrawal from acute opioid dependence. Liu J; Schulteis G Pharmacol Biochem Behav; 2004 Sep; 79(1):101-8. PubMed ID: 15388289 [TBL] [Abstract][Full Text] [Related]
32. Intrathecal clonidine: analgesia and effect on opiate withdrawal in the rat. Milne B; Cervenko FW; Jhamandas K; Sutak M Anesthesiology; 1985 Jan; 62(1):34-8. PubMed ID: 4038443 [TBL] [Abstract][Full Text] [Related]
33. Naloxone potentiation of novelty-induced hypoalgesia: characterization of the alpha-noradrenergic receptor subtype. Rochford J; Dawes P; Stewart J Pharmacol Biochem Behav; 1993 Feb; 44(2):381-6. PubMed ID: 8383341 [TBL] [Abstract][Full Text] [Related]
34. Role of imidazoline receptors in the anti-aversive properties of clonidine during opiate withdrawal in rats. Georges F; Caillé S; Vouillac C; Le Moine C; Stinus L Eur J Neurosci; 2005 Oct; 22(7):1812-6. PubMed ID: 16197523 [TBL] [Abstract][Full Text] [Related]
35. Effects of alpha 2-agonists on morphine withdrawal behaviour: potentiation of jumping mediated by alpha 2-receptors. van der Laan JW Naunyn Schmiedebergs Arch Pharmacol; 1985 May; 329(3):293-8. PubMed ID: 2862592 [TBL] [Abstract][Full Text] [Related]
36. Biochemical correlates of morphine withdrawal. 2. Effects of clonidine. DiStefano PS; Brown OM J Pharmacol Exp Ther; 1985 May; 233(2):339-44. PubMed ID: 4039756 [TBL] [Abstract][Full Text] [Related]
37. A pharmacological modulation of opiate withdrawal using an up-/down-regulation of the noradrenergic system in opiate-dependent rats. Streel E; Dan B; Campanella S; Meyvaert A; Hanak C; Pelc I; Verbanck P Int J Neuropsychopharmacol; 2006 Oct; 9(5):621-6. PubMed ID: 16146582 [TBL] [Abstract][Full Text] [Related]
38. Conditioning processes contribute to severity of naloxone-precipitated withdrawal from acute opioid dependence. Schulteis G; Morse AC; Liu J Psychopharmacology (Berl); 2004 Oct; 175(4):463-72. PubMed ID: 15083263 [TBL] [Abstract][Full Text] [Related]
39. Role of plasma catecholamines in eliciting cardiovascular changes seen during naloxone-precipitated withdrawal in conscious, unrestrained morphine-dependent rats. Chang AP; Dixon WR J Pharmacol Exp Ther; 1990 Sep; 254(3):857-63. PubMed ID: 2395117 [TBL] [Abstract][Full Text] [Related]
40. Evidence of a preferential role of brain serotonin in the mechanisms leading to naloxone-precipitated compulsive jumping in morphine-dependent rats. Cervo L; Rochat C; Romandini S; Samanin R Psychopharmacology (Berl); 1981; 74(3):271-4. PubMed ID: 6791237 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]